Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.
Also called NCT06007222
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 400 participants
- Sponsor
- OCEAN-SHD Study Group
- Registry
-
NCT06007222
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Japan
- Registry status
- Recruiting
Technical summary
Registry record NCT06007222. Randomized; no masking; primary purpose treatment. Start 2023-04-06 (actual); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial
- Condition
- Aortic Stenosis
- Condition
- TAVI(Transcatheter Aortic Valve Implantation)
- Condition
- Aspirin
- Condition
- DAPT(Dual Antiplatelet Therapy)
- Condition
- SAPT(Single Antiplatelet Therapy)
- Intervention (Drug)
- Aspirin group
- Intervention (Drug)
- Non-antithrombotic group
- Lead sponsor
- OCEAN-SHD Study Group
Record details
- Record id
cardio:ct-nct06007222- Content hash
9c3dff843bbcbed9df2cc0962bcef13be0d7a1b8e4ffbc0a90acad5bba09b47f